Dr. Jennifer Shum, MD

Dr. Shum practices at NewYork-Presbyterian Queens in Flushing, New York, part of NewYork-Presbyterian Hospital.

Dr. Shum's NPI, 1124361886, was assigned on April 1, 2013. Dr. Shum graduated from Stanford University School Of Medicine in 2013. Dr. Shum holds New York license 290379.

Dr. Shum's primary practice is NewYork-Presbyterian Queens, at 56-45 Main Street, Flushing, NY 11355 in Queens County. The practice phone is (718) 670-2000.

Dr. Shum's primary practice is NewYork-Presbyterian Queens in Flushing, New York, part of NewYork-Presbyterian Hospital. The medical group on file is NewYork-Presbyterian Medical Group Queens. Dmand AI also links Dr. Shum to 2 more group practices and clinics, 1 dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shum practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Shum's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Shum is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Shum's licenses on file in 2 states: New York and California.

Dmand AI lists epilepsy, essential tremor and seizures among the conditions Dr. Shum treats.

CMS data shows 577 Medicare services from Dr. Shum across 13 procedure codes in 2024, for 362 Medicare patients. Medicare paid $60,018 for them.

CMS counts 362 Medicare patients who saw Dr. Shum in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 65% are also on Medicaid. Their average risk score is 2.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shum's median patient age at 69, with 53% women.

In 2024, Dr. Shum wrote 1,254 Medicare Part D claims for 169 patients. 83% of them were for generic drugs. CMS names the drug for 1,086 of them, across 27 drugs with 11 or more claims each, at $205,750 in total drug cost. In 2023, CMS named 725 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Shum for performance year 2024, reported through an alternative payment model (APM). Dr. Shum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shum as offering telehealth.

Dmand AI links 6 papers to Dr. Shum, published from 2012 to 2021. 2020 was the busiest year, with 2. The most frequent topics are Brain Mapping, Electroencephalography and Image Processing, Computer-Assisted. Dr. Shum's most frequent co-authors are Patricia Cristine Dugan, MD, Mohammad Dastjerdi and Orrin Devinsky, MD.

CMS Open Payments shows 12 general payments to Dr. Shum from 9 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 94% of the total. Beckman Coulter, Inc. paid the most, $389.

Dmand AI lists 3 awards for Dr. Shum, most recently American Epilepsy Society Research and Training Fellowships for Clinicians in 2020.

Dr. Shum graduated from Stanford University School Of Medicine in 2013. Dr. Shum is a member of AAN, ACNS and AES.

Dr. Shum is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.